BioSpace News Archive

Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, today announced that the company will participate in the Cowen 42nd Annual Health Care Conference taking place virtually from March 7-9, 2022.

Candel Therapeutics, Inc. today announced that Seshu Tyagarajan Ph.D., RAC, has been named as the company’s Chief Technical and Development Officer.

Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced that management will participate in two investor conferences in March.

Vivos Therapeutics, Inc. announced that Kirk Huntsman, Chief Executive Officer, will participate in the following upcoming conferences.

Alimera Sciences, Inc. announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.

AmMax Bio, Inc. today announced additional positive results from the first-of-its-kind local delivery Phase 2 study of AMB-05X via intra-articular (IA) injection for the treatment of tenosynovial giant cell tumor (TGCT).

Sight Sciences, Inc. today announced that data from clinical studies of the OMNI ® Surgical System will be presented at the 2022 American Glaucoma Society (AGS) Annual Meeting.

Daré Bioscience, Inc. announced that members of its management team will participate in the following conferences.

Ceapro Inc. announced the appointment of leading international pharmaceutical industry executive, Ronnie Miller, to its Board of Directors.

Valencia Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its eCoin ® leadless tibial neurostimulator for the treatment of urinary incontinence (UUI), which affects over 60% of patients who suffer from Overactive Bladder (OAB).